Mark Iwicki
2021
In 2021, Mark Iwicki earned a total compensation of $2.8M as Chief Executive Officer at Kala Pharmaceuticals.
Compensation breakdown
| Bonus | $270,270 |
|---|---|
| Option Awards | $1,330,806 |
| Salary | $643,500 |
| Stock Awards | $521,360 |
| Other | $6,120 |
| Total | $2,772,056 |
Iwicki received $1.3M in option awards, accounting for 48% of the total pay in 2021.
Iwicki also received $270.3K in bonus, $643.5K in salary, $521.4K in stock awards and $6.1K in other compensation.
Rankings
In 2021, Mark Iwicki's compensation ranked 4,743rd out of 12,405 executives tracked by ExecPay. In other words, Iwicki earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,743 out of 12,405 | 62nd |
Division Manufacturing | 1,972 out of 5,494 | 64th |
Major group Chemicals And Allied Products | 829 out of 2,369 | 65th |
Industry group Drugs | 742 out of 2,090 | 65th |
Industry Pharmaceutical Preparations | 530 out of 1,537 | 66th |
Source: SEC filing on March 13, 2023.
Iwicki's colleagues
We found two more compensation records of executives who worked with Mark Iwicki at Kala Pharmaceuticals in 2021.